共 34 条
Continuous O2-Evolving MnFe2O4 Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer
被引:654
作者:
Kim, Jonghoon
[1
]
Cho, Hye Rim
[1
,2
,3
,4
]
Jeon, Hyejin
[1
,2
,3
,4
]
Kim, Dokyoon
[1
]
Song, Changyeong
[1
]
Lee, Nohyun
[5
]
Choi, Seung Hong
[1
,2
,3
,4
]
Hyeon, Taeghwan
[1
]
机构:
[1] Inst Basic Sci IBS, Ctr Nanoparticle Res, Seoul 08826, South Korea
[2] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 08826, South Korea
[3] Seoul Natl Univ, Inst Chem Proc, Seoul 08826, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul 03080, South Korea
[5] Kookmin Univ, Sch Adv Mat Engn, Seoul 02707, South Korea
基金:
新加坡国家研究基金会;
关键词:
MANGANESE FERRITE NANOPARTICLES;
TUMOR OXYGENATION;
FENTON REACTION;
IN-VIVO;
CELLS;
CHEMOTHERAPY;
ENHANCE;
RESISTANCE;
DOTS;
D O I:
10.1021/jacs.7b05559
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
Therapeutic effects of photodynamic therapy (PDT) are limited by cancer hypoxia because the PDT process is dependent on O-2 concentration. Herein, we design biocompatible manganese ferrite nanoparticle-anchored mesoporous silica nanoparticles (MFMSNs) to overcome hypoxia, consequently enhancing the therapeutic efficiency of PDT. By exploiting the continuous O-2-evolving property of MnFe2O4 nanoparticles through the Fenton reaction, MFMSNs relieve hypoxic condition using a small amount of nanoparticles and improve therapeutic outcomes of PDT for tumors in vivo. In addition, MFMSNs exhibit T-2 contrast effect in magnetic resonance imaging (MRI), allowing in vivo tracking of MFMSNs. These findings demonstrate great potential of MFMSNs for theranostic agents in cancer therapy.
引用
收藏
页码:10992 / 10995
页数:4
相关论文